• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外CCNU处理后暴露于米索前列醇的EMT-6/Ro细胞中的交联形成和化学增敏作用。

Cross-link formation and chemopotentiation of EMT-6/Ro cells exposed to MISO after CCNU treatment in vitro.

作者信息

Mulcahy R T

出版信息

Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1389-92. doi: 10.1016/0360-3016(86)90178-1.

DOI:10.1016/0360-3016(86)90178-1
PMID:3759561
Abstract

Experiments were designed to measure cross-link formation following combined treatment of EMT-6/Ro tumor cells with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and misonidazole (MISO) in vitro. To avoid MISO-induced glutathione (GSH) depletion, which might contribute to enhanced monoadduct formation by reducing the protective GSH pools, a post-incubation (i.e. treatment with CCNU for one hour in air followed by MISO treatment in hypoxia) protocol was adopted. Utilizing this treatment scheme, it was possible to significantly enhance CCNU toxicity by post-treating with MISO immediately after exposure to CCNU. Enhanced cross-link formation detected by alkaline elution, at this time, correlated well with the magnitude of cell-kill enhancement, thereby implicating enhanced cross-link formation in the mechanism of potentiation. However, if the cells were allowed to incubate for various intervals between CCNU and MISO treatments, the magnitude of potentiation progressively diminished. Beyond approximately 8-10 hours (corresponding to the time required for maximal cross-link formation after CCNU treatment), treatment with MISO was ineffective at potentiating CCNU cytotoxicity. These experiments suggest that chemopotentiation can be produced by treating with MISO after treatment with CCNU (post-incubation) and that enhanced cross-link formation is involved in the mechanism of MISO chemopotentiation of CCNU activity. The kinetic studies, using the post-incubation protocol, further suggest that the chemopotentiating effect of MISO is exerted subsequent to monoadduct formation and probably does not involve inhibition of DNA-DNA cross-link repair.

摘要

实验旨在体外测量1-(2-氯乙基)-3-环己基-1-亚硝基脲(CCNU)和米索硝唑(MISO)联合处理EMT-6/Ro肿瘤细胞后交联形成的情况。为避免MISO诱导的谷胱甘肽(GSH)耗竭,这可能通过减少保护性GSH池而导致单加合物形成增加,采用了孵育后方案(即在空气中用CCNU处理1小时,然后在缺氧条件下用MISO处理)。利用这种处理方案,在暴露于CCNU后立即用MISO进行后处理,可以显著增强CCNU的毒性。此时,通过碱性洗脱检测到的交联形成增强与细胞杀伤增强的程度密切相关,从而表明交联形成增强参与了增效机制。然而,如果在CCNU和MISO处理之间让细胞孵育不同的时间间隔,增效程度会逐渐降低。超过大约8-10小时(对应于CCNU处理后最大交联形成所需的时间),用MISO处理对增强CCNU细胞毒性无效。这些实验表明,CCNU处理后用MISO处理(孵育后)可产生化学增效作用,且交联形成增强参与了MISO对CCNU活性的化学增效机制。使用孵育后方案的动力学研究进一步表明,MISO的化学增效作用在单加合物形成之后发挥,可能不涉及对DNA-DNA交联修复的抑制。

相似文献

1
Cross-link formation and chemopotentiation of EMT-6/Ro cells exposed to MISO after CCNU treatment in vitro.体外CCNU处理后暴露于米索前列醇的EMT-6/Ro细胞中的交联形成和化学增敏作用。
Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1389-92. doi: 10.1016/0360-3016(86)90178-1.
2
Misonidazole-induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea toxicity in O6-methylguanine-DNA methyltransferase proficient (Mer+) and deficient (Mer-) cell lines.米索硝唑对O6-甲基鸟嘌呤-DNA甲基转移酶功能正常(Mer+)和缺陷(Mer-)细胞系中1-(2-氯乙基)-3-环己基-1-亚硝基脲毒性的化学增敏作用。
Cancer Res. 1986 Jun;46(6):2892-7.
3
Carbamoylation, inhibition of glutathione reductase and chemopotentiation of nitrosoureas by misonidazole.米索硝唑对氨甲酰化、谷胱甘肽还原酶的抑制作用以及亚硝基脲类药物的化疗增敏作用。
Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1393-5. doi: 10.1016/0360-3016(86)90179-3.
4
Enhancement of misonidazole chemopotentiation by mild hyperthermia (41 degrees C) in vitro and selective enhancement in vivo.
Int J Radiat Biol Relat Stud Phys Chem Med. 1987 Jul;52(1):57-65. doi: 10.1080/09553008714551481.
5
Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.米索硝唑增强洛莫司汀的细胞毒性:可能的治疗获益。
Br J Cancer. 1982 Jul;46(1):109-16. doi: 10.1038/bjc.1982.172.
6
Chemopotentiation in vivo: no loss of sensitization with fractionation.体内化学增敏作用:分次照射不会导致敏化作用丧失。
Br J Cancer. 1984 Oct;50(4):509-17. doi: 10.1038/bjc.1984.208.
7
In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.米索硝唑对敏感和耐药肿瘤细胞系的体内化学增敏作用。
Cancer Res. 1983 Oct;43(10):4709-13.
8
Enhanced tumor responses through therapies combining CCNU, MISO and radiation.通过联合使用洛莫司汀、米索前列醇和放疗的疗法增强肿瘤反应。
Int J Radiat Oncol Biol Phys. 1984 Sep;10(9):1623-6. doi: 10.1016/0360-3016(84)90515-7.
9
Potentiation of CCNU activity by misonidazole in metastases.米索硝唑增强环己亚硝脲在转移灶中的活性。
Clin Exp Metastasis. 1987 Jan-Mar;5(1):57-63. doi: 10.1007/BF00116626.
10
Chemosensitization of the nitrosoureas by 2-nitroimidazoles in the subcutaneous 9L tumor model: pharmacokinetic and structure-activity considerations.2-硝基咪唑对亚硝基脲在皮下9L肿瘤模型中的化学增敏作用:药代动力学及构效关系考量
Int J Radiat Oncol Biol Phys. 1990 May;18(5):1043-50. doi: 10.1016/0360-3016(90)90439-q.

引用本文的文献

1
Phase I/pharmacokinetic/biochemical study of the nitroimadazole hypoxic cell sensitiser SR2508 (etanidazole) in combination with cyclophosphamide.硝基咪唑类乏氧细胞增敏剂SR2508(依他硝唑)与环磷酰胺联合应用的I期/药代动力学/生化研究
Br J Cancer. 1993 Oct;68(4):756-66. doi: 10.1038/bjc.1993.424.
2
Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.米索硝唑对洛莫司汀处理的球体和肿瘤的化学增敏作用。
Br J Cancer. 1987 Aug;56(2):103-9. doi: 10.1038/bjc.1987.165.